Regeneron Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
REGN Regeneron Pharmaceuticals Inc
LII Lennox International Inc
SAN Banco Santander SA
AXP American Express Co
GRPN Groupon Inc
JPM JPMorgan Chase & Co
BIDU Baidu Inc
PJET Priority Aviation Inc
CY Cypress Semiconductor Corp
UOCT Innovator S&P 500 Ultra Buffer ETF - October
Go

Health Care : Biotechnology | Large Cap GrowthCompany profile

Regeneron Pharmaceuticals, Inc. is a biopharmaceutical company that discovers, invents, develops, manufactures and commercializes medicines for the treatment of serious medical conditions. The Company commercializes medicines for eye diseases, high low-density lipoprotein (LDL) cholesterol, and an inflammatory condition and have product candidates in development in other areas, including rheumatoid arthritis, asthma, atopic dermatitis, pain, cancer, and infectious diseases. The Company's marketed products include EYLEA (aflibercept) Injection, Praluent (alirocumab) Injection, ARCALYST (rilonacept) Injection for Subcutaneous Use, Kevzara (sarilumab) Solution for Subcutaneous Injection and ZALTRAP (ziv-aflibercept) Injection for Intravenous Infusion. As of December 31, 2016, the Company had 16 product candidates in clinical development, which consisted of a Trap-based clinical program and 15 fully human monoclonal antibody product candidates.

Postmarket

Last Trade
Delayed
$334.03
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$334.03
Day's Change
0.69 (0.21%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
336.00
Day's Low
329.00
Volume
(Below Average)
Volume:
915,644

10-day average volume:
1,038,183
915,644
  • Prev Close
    333.34
  • Today's Open
    332.50
  • Day's Range
    329.00-336.00
  • Avg Vol (10-day)
    1.0M
  • Last (time)
    4:00p ET 04/22/19
  • Last (size)
    10
  • 52-Wk Range
    281.89 - 442.00
    LowHigh
  • (05/09/18 - 03/04/19)
    18.50%
  • 31.5%
  • Market Cap
    35.9B
  • Shares Outstanding
    107.4M
  • 20.70
  • 16.10x
  • No dividend
  • Ex-dividend
    No dividend
  • 1.1
  • 71.37
  • (% of float 03/29/19)
    2.58

Latest News

April 08, 2019
4:01 pm ET
PR Newswire
7:06 am ET
BusinessWire
7:00 am ET
PR Newswire
April 05, 2019
8:06 am ET
BusinessWire
April 04, 2019
9:36 am ET
Zacks
April 01, 2019
7:45 am ET
PR Newswire
March 27, 2019
10:09 am ET
Globe Newswire
March 25, 2019
7:39 am ET
Globe Newswire
March 15, 2019
4:01 pm ET
PR Newswire
March 13, 2019
12:13 pm ET
MarketWatch
7:00 am ET
PR Newswire
March 12, 2019
11:02 pm ET
PR Newswire
9:56 pm ET
PR Newswire
11:36 am ET
PR Newswire
March 11, 2019
3:45 pm ET
PR Newswire
3:44 pm ET
PR Newswire
1:00 am ET
PR Newswire
March 08, 2019
4:01 pm ET
PR Newswire
12:59 am ET
PR Newswire
March 01, 2019
8:35 am ET
PR Newswire
6:59 am ET
PR Newswire
February 27, 2019
8:09 am ET
Globe Newswire
February 25, 2019
5:22 pm ET
PR Newswire
12:44 pm ET
PR Newswire
February 15, 2019
4:42 pm ET
PR Newswire
February 14, 2019
12:02 pm ET
MarketWatch
9:30 am ET
PR Newswire
February 12, 2019
8:29 am ET
Globe Newswire
February 11, 2019
7:17 am ET
MarketWatch
7:08 am ET
MarketWatch
7:00 am ET
PR Newswire
6:59 am ET
PR Newswire
February 09, 2019
4:30 pm ET
PR Newswire
February 06, 2019
6:30 am ET
PR Newswire
February 04, 2019
12:59 am ET
PR Newswire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2019 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2019. All rights reserved.